On July 23, 2019, together with MESSILA – Medical Startup Academy, we hosted a joint workshop for medical technology companies. Ron Kimhi held a lecture on entry to the US market and
Kengo Akano about entry to the Japanese market.
Perhaps unsurprisingly, we at ERM are currently assisting several clients (both lenders and borrowers) to navigate material adverse change (MAC) provisions in this time of uncertainty. A MAC clause is included in the vast majority of Israeli financing documents. As in other global financing documents, and broadly speaking, such provisions set a measure for when […]